Kyle Detwiler, CEO of multinational medical cannabis operator Clever Leaves Holdings, discusses how Clever Leaves is supporting the Colombian community from which they hail, what they’re doing to help guarantee patient access amid a global supply chain crisis, and how they’re becoming a global presence in the medical cannabis space. He also explains Project Change Lives, an initiative through which Clever Leaves has committed to donating $25 million USD worth of cannabis to research institutions, in an effort to account for decades of missed opportunities into researching the medical benefits of the plant.
Kyle Detwiler is CEO of Clever Leaves. Prior to the integration of Northern Swan and Clever Leaves in 2019, Detwiler served as CEO and co-founder of Northern Swan Holdings as well as co-founded Silver Swan Capital, an investment firm focused on niche and underfollowed sectors. He was also a Principal at The Blackstone Group, a leading alternative investment manager with $619 billion in assets under management. As an early member of the Tactical Opportunities Fund, Mr. Detwiler was involved in the management and served as a board member of seven investments with roughly $1 billion of Blackstone capital. Mr. Detwiler was previously a member of the private equity practice at KKR, focusing on transactions in the oil and gas, energy, natural resource and health care sectors. He began his career as an investment banker at Morgan Stanley. Detwiler graduated with distinction from Harvard Business School and cum laude from Princeton University.